Meeting
2014 ASCO Annual Meeting
Use of a SNP panel to refine risk estimates in women at high risk of breast cancer: Results from two randomized tamoxifen prevention trials.
Authors
Jack M. Cuzick
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, London, United Kingdom
Jack M. Cuzick , Adam Brentnall , Corrinne Segal , Ivana Sestak , Roseann Kealy , Anthony Howell , Trevor J. Powles , Nicholas Orr , William G. Newman , Mitchell Dowsett
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Highlights Session
Session Title
Cancer Prevention/Epidemiology
Track
Cancer Prevention/Epidemiology
Sub Track
Cancer Genetics
Clinical Trial Registration Number
ISRCTN91879928 (ref: CCT-NAPN-14839)
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 1519)
DOI
10.1200/jco.2014.32.15_suppl.1519
Abstract #
1519
Poster Bd #
8
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Association of baseline plasma levels of 25OH vitamin D and breast cancer risk in a chemoprevention trial.
First Author: Bernardo Bonanni
Poster
2014 ASCO Annual Meeting
Patient-reported outcomes and behavioral risk factors as predictors of chemoprevention adherence among women in the National Surgical Adjuvant Breast and Bowel Program (NSABP) Breast Cancer Prevention P-1 trial.
First Author: Stephanie R. Land
Poster
2011 ASCO Annual Meeting
Incremental impact of breast cancer SNP panel on risk classification and screening.
First Author: K. Armstrong
Poster
2024 ASCO Breakthrough
Exploring depression risk among breast cancer survivors: A nationwide cohort study in South Korea.
First Author: Hea Lim Choi